Mark Walderhaug

Mark Walderhaug is an interdisciplinary scientist who builds bridges of understanding between complex quantitative risk-benefit models and the decision-makers who need to use these models to improve public health. Dr. Walderhaug works on risk-benefit models for pandemic flu, malaria, and vaccines. He is working on facilitating development of mathematical benefit-risk models that run in a high performance computing environment. He has worked on FDA's Vibrio parahaemolyticus and Listeria monocytogenes risk assessments. He has served as a temporary advisor to the joint FAO/WHO expert consultation on risk assessment of Vibrio spp. in seafood. He has participated in foreign training and foreign inspections for the FDA. He has received two FDA Awards of Merit and two Commissioner's Special Citations. He earned his Ph.D. at Vanderbilt University.